Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.34 |
| ▸ | ALB | P02768 | 2/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10880463 | 0.87 | TTR (0.42) | TTRALBFFAR4MCL1MEN1 | |
| SCHEMBL6667915 | 0.84 | TTR (0.41) | TTRALBFFAR4MCL1MEN1 | |
| SCHEMBL26002403 | 0.77 | TTR (0.35) | TTRALBFFAR4MCL1MEN1 | |
| SCHEMBL10204233 | 0.77 | ALDH1A1 (0.39) | TTRALBFFAR4MEN1KMT2A | |
| SCHEMBL16960440 | 0.77 | TTR (0.35) | TTRALBFFAR4MCL1MEN1 | |
| SCHEMBL26345761 | 0.77 | GABRA1 (0.37) | — | |
| SCHEMBL19120276 | 0.77 | TTR (0.40) | TTRALBMEN1KMT2A | |
| SCHEMBL25547481 | 0.77 | GABRA1 (0.37) | — | |
| SCHEMBL15958517 | 0.76 | ALDH1A1 (0.42) | RORC | |
| SCHEMBL16960599 | 0.75 | TTR (0.34) | TTRALBFFAR4MCL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040087-A1 | SOMATOSTATIN MODULATORS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040087-A1 | SOMATOSTATIN MODULATORS AND USES THEREOF | SSTR5, SSTR2, SSTR4 | TTR 1089/4885ALB 3218/4885FFAR4 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.